Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.

OBJECTIVE:

Review of the literature regarding hearing loss in patients with head and neck cancer treated with chemoradiation.

DESIGN:

Studies in the literature are reviewed that pertain to hearing loss sustained in head and neck cancer patients receiving cisplatin-based chemoradiation. Personal observations noted while treating these patients are also detailed.

STUDY SAMPLE:

PubMed was searched for pertinent articles regarding hearing loss in head and neck cancer patients receiving cisplatin chemotherapy and/or radiation.

RESULTS:

Studies on the incidence and severity of hearing loss in head and neck cancer patients are limited, but those studies suggest that the risk of hearing loss is greater with higher-dose regimens.

View Abstract

Related Authors